AGP Limited (KASE : AGP) agreed to acquire Portfolio of Products of Viatris Inc. on June 14, 2022. The portfolio comprises a variety of products including, a broad range of anti-depressants and anti-hypertensive products. Some of the well-known products in the portfolio are Xanax®, Norvasc®, Cardura®, Zoloft®, Lipitor®, and Effexor®. AGP will acquire the Brands through an optimal capital structure comprising equity and debt in the ratio of 25:75. The acquisition is subject to necessary regulatory approvals, corporate approvals, and approval of AGP Limited's shareholders. The board of AGP Limited has approved the deal.

AGP Limited (KASE : AGP) completed the acquisition of Portfolio of Products of Viatris Inc. on April 8, 2023.